Clinical trial
A Non-invasive, Prolonged Surveillance Strategy Using Apple Watch for Atrial Fibrillation Detection in Cryptogenic Stroke
NCT05007847 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-invasive, Prolonged Surveillance Strategy Using Apple Watch for Atrial Fibrillation Detection in Cryptogenic Stroke
- Lead sponsor
- Barts & The London NHS Trust
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 4, 2022
- Completion date
- February 28, 2025
- Enrollment
- 27 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, cryptogenic stroke